Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis.

MLA

Gonzalez Moret, Yurilu A., et al. “Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis.” ACR Open Rheumatology, vol. 6, no. 8, Aug. 2024, pp. 497–503. EBSCOhost, https://doi.org/10.1002/acr2.11698.

APA

Gonzalez Moret, Y. A., Lo, K. B., & Tan, I. J. (2024). Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis. ACR Open Rheumatology, 6(8), 497–503. https://doi.org/10.1002/acr2.11698

Chicago

Gonzalez Moret, Yurilu A, Kevin Bryan Lo, and Irene J Tan. 2024. “Metformin in Systemic Lupus Erythematosus: Investigating Cardiovascular Impact and Nephroprotective Effects in Lupus Nephritis.” ACR Open Rheumatology 6 (8): 497–503. doi:10.1002/acr2.11698.